Kelvin C. Teo

11 Third Hospital Ave
Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Variations in nAMD and PCV Phenotypes and Treatment Outcomes Across Singaporean, Canadian Asian, and Canadian Caucasian Populations.

Variations in nAMD and PCV Phenotypes and Treatment Outcomes Across Singaporean, Canadian Asian, and Canadian Caucasian Populations.

Journal: American journal of ophthalmology

Published: April 17, 2026

Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg.

Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg.

Journal: Ophthalmology and therapy

Published: March 13, 2026

Predictors of 1-Year Visual Outcome in Central-Involving Submacular Hemorrhage Secondary to Neovascular AMD.

Predictors of 1-Year Visual Outcome in Central-Involving Submacular Hemorrhage Secondary to Neovascular AMD.

Journal: American journal of ophthalmology

Published: January 29, 2026

Using OCT Angiography to Predict Diabetic Retinopathy Progression and Vision Decline in a Multiethnic Cohort.

Using OCT Angiography to Predict Diabetic Retinopathy Progression and Vision Decline in a Multiethnic Cohort.

Journal: Ophthalmology science

Published: October 25, 2025

Initial Experiences of Switching to Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration and Polypoidal Chorodal Vasculopathy in an Asian Population.

Initial Experiences of Switching to Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration and Polypoidal Chorodal Vasculopathy in an Asian Population.

Journal: Ophthalmology and therapy

Published: September 27, 2025

Standardization of Imaging Criteria for Detecting Macular Fibrosis in Neovascular Age-Related Macular Degeneration.

Standardization of Imaging Criteria for Detecting Macular Fibrosis in Neovascular Age-Related Macular Degeneration.

Journal: Ophthalmology science

Published: July 14, 2025

Fundus Autofluorescence (FAF) Alteration in Polypoidal Choroidal Vasculopathy (PCV) and Typical Neovascular Age Related Macular Degeneration (tAMD).

Fundus Autofluorescence (FAF) Alteration in Polypoidal Choroidal Vasculopathy (PCV) and Typical Neovascular Age Related Macular Degeneration (tAMD).

Journal: Retina (Philadelphia, Pa.)

Published: May 15, 2025

INCIDENCE AND RISK FACTORS FOR PROGRESSION OF PACHYCHOROID DISEASE SPECTRUM.

INCIDENCE AND RISK FACTORS FOR PROGRESSION OF PACHYCHOROID DISEASE SPECTRUM.

Journal: Retina (Philadelphia, Pa.)

Published: February 18, 2025

Progression of Loss of Vision From Centre-Involving Macular Atrophy in Eyes Treated for nAMD.

Progression of Loss of Vision From Centre-Involving Macular Atrophy in Eyes Treated for nAMD.

Journal: Clinical & experimental ophthalmology

Published: January 08, 2025

Consensus and guidelines on diagnosis and management of polypoidal choroidal vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS).

Consensus and guidelines on diagnosis and management of polypoidal choroidal vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS).

Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

Published: December 27, 2024

AI explainability in oculomics: How it works, its role in establishing trust, and what still needs to be addressed.

AI explainability in oculomics: How it works, its role in establishing trust, and what still needs to be addressed.

Journal: Progress in retinal and eye research

Published: November 03, 2024

Unexpected retinal fluid compartment responses with anti-VEGF therapy in polypoidal choroidal vasculopathy: a case report of four patients.

Unexpected retinal fluid compartment responses with anti-VEGF therapy in polypoidal choroidal vasculopathy: a case report of four patients.

Journal: Frontiers in ophthalmology

Published: October 10, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026